Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes

Clicks: 162

ID: 116078

2012

Reference Key	salaroli2012annalsfasting Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors	Adriano Salaroli;Giuseppina Loglisci;Alessandra Serrao;Giuliana Alimena;Massimo Breccia;Adriano Salaroli;Giuseppina Loglisci;Alessandra Serrao;Giuliana Alimena;Massimo Breccia;
Journal	Annals of hematology
Year	2012
DOI	doi:10.1007/s00277-012-1493-3
URL	https://link.springer.com/article/10.1007/s00277-012-1493-3 https://doi.org/doi:10.1007/s00277-012-1493-3
Keywords	oncology hematology

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.